KEQU KEQU
Company Profile ↓Company Overview
KEQU (KEQU) is a publicly traded company listed on . The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 11.3.
Recent Developments
- Apr 2026 Revenue of $282.00M (+17.3% YoY); net profit $9.62M.
- Trailing 12 Months Year-on-year growth — revenue +17.3%, earnings -15.7%.
- 5-Year Trend Long-term compounding — revenue CAGR 6.8%, profit CAGR 6.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | 6.75% |
| 1 Year: | 17.27% |
Compounded Profit Growth
| 5 Years: | 6.39% |
| 1 Year: | -15.67% |
Stock Price Performance
| 1 Year: | -34.27% |
| 6 Months: | -10.15% |
| 3 Months: | -2.05% |
| 1 Month: | -0.14% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMABelow
- Price vs 200-DMABelow
- RSI (14)49.03 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
No notable strengths flagged.
CONS
- Trading 36.9% below its 52-week high.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Jul 2015 | Oct 2015 | Jan 2016 | Apr 2016 | Jul 2016 | Oct 2016 | Jan 2017 | Apr 2017 | Jul 2017 | Oct 2017 | Jan 2018 | Apr 2018 | Jul 2018 | Oct 2018 | Jan 2019 | Apr 2019 | Jul 2019 | Oct 2019 | Jan 2020 | Apr 2020 | Jul 2020 | Oct 2020 | Jan 2021 | Apr 2021 | Jul 2021 | Oct 2021 | Jan 2022 | Apr 2022 | Jul 2022 | Oct 2022 | Jan 2023 | Jul 2023 | Oct 2023 | Jan 2024 | Jul 2024 | Oct 2024 | Jan 2025 | Jul 2025 | Oct 2025 | Jan 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | 37.28M | 36.33M | 30.37M | 34.58M | 33.88M | 41.47M | 38.19M | 44.51M | 42.15M | 37.28M | 32.37M | 34.75M | 39.34M | 39.72M | 34.23M | 34.26M | 36.42M | 39.00M | 33.34M | 38.71M | 39.49M | 39.03M | 40.63M | 49.72M | 50.12M | 54.56M | 60.82M | 49.84M | 50.44M | 46.78M | 48.39M | 47.76M | 67.17M | 71.10M | 70.10M | 69.40M |
| Gross Profit | 5.84M | 5.53M | 5.49M | 6.84M | 7.14M | 7.10M | 5.03M | 7.33M | 6.82M | 7.91M | 8.31M | 9.12M | 7.58M | 7.66M | 5.23M | 4.84M | 6.95M | 6.32M | 5.28M | 4.89M | 5.88M | 6.39M | 5.65M | 6.06M | 5.67M | 3.60M | 5.62M | 9.33M | 6.20M | 8.70M | 10.33M | 11.91M | 13.47M | 12.03M | 12.49M | 13.95M | 18.38M | 20.93M | 19.72M | 18.55M |
| Operating Income | 1.52M | 1.13M | 1.05M | - | 2.06M | 2.29M | 442.00K | - | 1.69M | 2.65M | 2.43M | - | 1.82M | 1.70M | -2.00K | - | 776.00K | -39.00K | -2.07M | - | -276.00K | -11.00K | -376.00K | - | -1.09M | -2.89M | -868.00K | - | -396.00K | 755.00K | 2.30M | 3.81M | 5.11M | 3.81M | 2.58M | 4.43M | 2.25M | 4.81M | 4.11M | 2.58M |
| Net Income | 940.00K | 695.00K | 830.00K | 1.34M | 1.30M | 1.49M | 341.00K | 1.39M | 1.15M | 1.72M | 853.00K | 1.56M | 1.49M | 1.33M | -22.00K | -1.27M | 471.00K | -2.18M | -1.92M | -1.06M | -598.00K | -180.00K | 81.00K | -2.98M | -1.34M | -3.10M | -1.32M | -362.00K | -747.00K | -243.00K | 723.00K | 2.47M | 2.73M | 2.52M | 2.19M | 3.01M | 1.35M | 3.09M | 2.44M | 692.00K |
| Diluted EPS | 0.35 | 0.26 | 0.31 | 0.50 | 0.48 | 0.54 | 0.13 | 0.51 | 0.42 | 0.62 | 0.30 | 0.56 | 0.53 | 0.48 | -0.01 | -0.46 | 0.17 | -0.79 | -0.70 | -0.39 | -0.22 | -0.07 | 0.03 | -1.08 | -0.48 | -1.11 | -0.47 | -0.13 | -0.27 | -0.09 | 0.25 | 0.86 | 0.93 | 0.85 | 0.74 | 1.01 | 0.45 | 1.04 | 0.82 | 0.23 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Apr 2010 | Apr 2011 | Apr 2012 | Apr 2013 | Apr 2014 | Apr 2015 | Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 99.09M | 100.00M | 102.85M | 117.12M | 111.17M | 118.83M | 128.63M | 138.56M | 158.05M | 146.55M | 147.54M | 147.47M | 168.87M | 219.49M | 203.75M | 240.47M | 282.00M |
| Gross Profit | 21.40M | 19.28M | 19.16M | 22.26M | 22.03M | 21.77M | 23.71M | 26.61M | 32.16M | 25.32M | 23.43M | 23.99M | 24.22M | 35.59M | 52.05M | 68.86M | 80.44M |
| Operating Income | 5.83M | 3.16M | 2.71M | 5.28M | 5.96M | 5.23M | 5.70M | 6.54M | 9.92M | 2.11M | -2.35M | -1.32M | -2.61M | 5.36M | 18.28M | 17.76M | 16.71M |
| Net Income | 3.57M | 1.85M | 1.03M | 3.04M | 3.90M | 3.53M | 3.80M | 4.51M | 5.28M | 1.53M | -4.69M | -3.67M | -6.13M | 738.00K | 18.75M | 11.40M | 9.62M |
| Diluted EPS | 1.39 | 0.72 | 0.40 | 1.17 | 1.48 | 1.33 | 1.42 | 1.66 | 1.90 | 0.55 | -1.70 | -1.33 | -2.20 | 0.25 | 6.38 | 3.83 | 3.22 |
| R&D Expense | - | 1.18M | 941.00K | 872.00K | 842.00K | 936.00K | 1.17M | 1.16M | 1.54M | 1.55M | 1.82M | 1.41M | 990.00K | 1.01M | 920.00K | 919.00K | 898.00K |
Balance Sheet (Annual)
Figures in USD.
| Metric | Apr 2009 | Apr 2010 | Apr 2011 | Apr 2012 | Apr 2013 | Apr 2014 | Apr 2015 | Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Jun 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | - | - | 63.06M | 63.36M | 68.74M | 62.72M | 69.49M | 72.41M | 80.92M | 85.08M | 87.22M | 83.93M | 89.38M | 118.77M | - | 118.90M | 134.77M | 194.65M | 178.31M |
| Total Equity | 26.95M | 30.43M | 31.49M | 29.51M | 31.68M | 33.96M | 34.88M | 38.24M | 43.46M | 47.73M | 47.10M | 38.41M | 41.24M | 35.69M | - | 37.41M | 54.76M | 64.46M | 74.72M |
| Cash & Equivalents | 3.56M | 1.72M | 2.40M | 6.19M | 5.81M | 6.25M | 3.04M | 5.22M | 12.51M | 9.72M | 10.65M | 4.37M | 5.21M | 4.43M | - | 8.08M | 23.27M | 14.94M | 9.95M |
| Long Term Debt | - | - | 3.67M | 3.47M | 3.27M | 4.19M | 3.77M | 3.35M | 2.43M | 1.26M | 97.00K | 0 | - | - | 0 | - | - | 34.69M | 15.08M |
| Total Liabilities | - | - | 30.04M | 31.70M | 35.05M | 28.49M | 34.29M | 33.85M | 37.66M | 36.89M | 39.52M | 45.23M | 47.90M | 82.59M | - | 80.41M | 78.56M | 128.41M | 101.50M |
| Current Liabilities | - | - | 20.26M | 19.46M | 22.11M | 16.16M | 21.05M | 20.95M | 26.93M | 27.62M | 32.73M | 27.06M | 34.18M | 42.29M | - | 40.05M | 40.78M | 53.71M | 48.35M |
Cash Flows (Annual)
Figures in USD.
| Metric | Apr 2010 | Apr 2011 | Apr 2012 | Apr 2013 | Apr 2014 | Apr 2015 | Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | 4.53M | 1.27M | 6.92M | 3.83M | - | - | 7.27M | 11.66M | 3.18M | 2.49M | 4.16M | 912.00K | -7.88M | -3.79M | 19.56M | 14.78M | 18.63M |
| Investing Cash Flow | -4.33M | -5.26M | -1.59M | -2.39M | - | - | -1.48M | -2.48M | -3.40M | -4.21M | -2.46M | -2.40M | -1.91M | -4.15M | -4.37M | -30.90M | -3.94M |
| Financing Cash Flow | -2.29M | 4.50M | -1.09M | -1.72M | - | - | -3.40M | -2.08M | -2.48M | 2.33M | -7.46M | 1.98M | 11.03M | 14.93M | -3.01M | 7.41M | -19.33M |
| Share Buybacks | - | - | - | - | - | - | - | - | - | - | - | - | - | 0 | 2.00M | 1.60M | 0 |
| Dividends Paid | 976.00K | 1.03M | 1.03M | 1.03M | 1.12M | 1.23M | 1.36M | 1.57M | 1.79M | 2.03M | - | - | - | - | - | - | - |
Ratios (Annual)
Figures in %.
| Metric | Apr 2010 | Apr 2011 | Apr 2012 | Apr 2013 | Apr 2014 | Apr 2015 | Apr 2016 | Apr 2017 | Apr 2018 | Apr 2019 | Apr 2020 | Apr 2021 | Apr 2022 | Apr 2023 | Apr 2024 | Apr 2025 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin % | 21.6% | 19.3% | 18.6% | 19.0% | 19.8% | 18.3% | 18.4% | 19.2% | 20.3% | 17.3% | 15.9% | 16.3% | 14.3% | 16.2% | 25.5% | 28.6% | 28.5% |
| Operating Margin % | 5.9% | 3.2% | 2.6% | 4.5% | 5.4% | 4.4% | 4.4% | 4.7% | 6.3% | 1.4% | -1.6% | -0.9% | -1.5% | 2.4% | 9.0% | 7.4% | 5.9% |
| Net Margin % | 3.6% | 1.8% | 1.0% | 2.6% | 3.5% | 3.0% | 3.0% | 3.3% | 3.3% | 1.0% | -3.2% | -2.5% | -3.6% | 0.3% | 9.2% | 4.7% | 3.4% |
| ROE % | 11.7% | 5.9% | 3.5% | 9.6% | 11.5% | 10.1% | 9.9% | 10.4% | 11.1% | 3.2% | -12.2% | -8.9% | -17.2% | 2.0% | 34.2% | 17.7% | 12.9% |
| ROCE % | - | 7.4% | 6.2% | 11.3% | 12.8% | 10.8% | 11.1% | 12.1% | 17.3% | 3.9% | -4.1% | -2.4% | -3.4% | 6.8% | 19.5% | 12.6% | 12.9% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for KEQU
(KEQU) Movement as an Input in Quant Signal Sets - Stock Traders Daily
<a href="https://news.google.com/rss/articles/CBMixgFBVV95cUxQQUxDTXBvMF9fWHkxcHVjdW9kLTdiSXZlYS1ROTlXWmlmYk0td0M1aDJZck5fMU5BeWVhbjBQSVJkMG8wMjl2alFwMTJoWmVGSFJuUmRMaXdlYXhITmZXdVRfNkZNUnh4TG9GT0dRNkRLb2ZsUmVGazNKUEVpbzEyRWktMHMtZXBFMi10VW…
Kewaunee Scientific to Report Results for Fiscal Year and Fourth Quarter - PR Newswire
<a href="https://news.google.com/rss/articles/CBMixwFBVV95cUxPNjZ3SGx0ckJWM1RJQzlJTDZJRE9aTDdNQlhuRzU3WjREZXNscDdacXV5NnFPUHB2MDdHR1N2bkUwRzNzLUdUSzJTYzhHWlFnbUFxeWoteTc3QU04TmNRNkY4cW84UXg1TWpGQ2ZST3JudldYWHMyeXpzcEM3TDRILTQ1MHQ0aG90Y0k0QW…
Kewaunee Scientific Corp (KEQU) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
<a href="https://news.google.com/rss/articles/CBMicEFVX3lxTE0wc1ZNQzQtcTR2Q05DeGZxSmRmMHZBaW1nR0NBc3FaZUo1VkRTS0hGRzkzeHJQbkdhLTR5aXBicUFTYm5KeEtXWDJUNlBvRXZTSUtYYXBHNURiWjFUMUZGaWI2ZTJSUFBxbVlia0pnRm4?oc=5" target="_blank">Kewaunee Scienti…
KEWAUNEE SCIENTIFIC CORP /DE/ SEC Filing (Jul 7, 2026) - Stock Titan
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQNHRIcW5OOV8yeUlEMDB4X1Rqa0MtVTRVbVoxMkVJaGU1aUUtX3VYSlpkUW5CZWdDVDl1eVVkcGhiYmM5dzljUXJxcjFMRFBoSW12ODJWamh2YUZYOWZFYU45a1I1bU9wNU5pWnREU0stb0ZfSy01SDVhUnJhcmFycDB0cWJhU1lENGtMWk…
Kewaunee Scientific Reports Results for Fiscal Year and Fourth Quarter - PR Newswire
<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxQQ19iemRJS0wwYTYzeEhTWFVvcjJoRWE1QU1kZm1SSzRjR0d1OEp1OWR5RUdnakg2QTV2dVFHanF4TFdNbHoxTThmY1AtcEg5bU96VTFMQURJY3VWMVltRkE4LTlOWHUzcmVmdTdWRXBXNTlHaG9salI0TVIwMHVLMWNuWGM4SkJHcGZSY1…
Kewaunee Scientific: Backlog Suggests That A Tough Year Is Ahead (NASDAQ:KEQU) - Seeking Alpha
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxNUlVGLThjX0xqZUZtT0JDQ3RVT24zWFpMTDQ5Z2JPOTNxRzZGaGVtRE5QYlI1NmNxb2w1WFpmb1Z4bEkzMjdXeXhMMGJaOFBHSVo0WjJUUmhQdXpWTDBXU0tOaXg4NFBLbVF1VEphVjRsaVdKeGxjcDFoeFpSSzBTT0xRYUxXcWdHM3hsV1…
KEQU — Frequently Asked Questions
What is the current share price of KEQU?
As of 2026-08-05 17:25 PDT, KEQU trades at $36.40 on NASDAQ/NYSE. Its 52-week range is $33.97 to $57.68.
What is the P/E ratio of KEQU?
KEQU trades at a trailing price-to-earnings (P/E) ratio of 11.30.
What is the return on equity (ROE) of KEQU?
KEQU has a return on equity (ROE) of 12.87%. Its return on capital employed (ROCE) is 12.86%.
Is KEQU a good stock to buy?
This page provides a data-driven analysis of KEQU, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.